Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Annual Review of Psychology|January 28, 2004
The intergenerational transfer of psychosocial risk: mediators of vulnerability and resilienceLisa A Serbin, Jennifer KarpCVIR Endovascular|April 2, 2024
Single-procedure 8Fr rheolytic pharmacomechanical thrombectomy for treatment of acute iliofemoral deep venous thrombosisNicholas Xiao, Matthew Genet, Rocio Marquez Karry, et al.Journal of Forensic Sciences|October 15, 2013
The role of DNA-stained currency in gang robberies within the United KingdomBreanna K Mead, James Hayward, Benjamin Liang, et al.Journal of Clinical and Diagnostic Research : JCDR|January 28, 2016
The Role of Potentially Retrievable Inferior Vena Cava Filters in High-Risk Patients Undergoing Joint ArthroplastySabeen Dhand, S David Stulberg, Lalit Puri, et al.Journal of Vascular and Interventional Radiology : JVIR|November 27, 2012
Optional or permanent: clinical factors that optimize inferior vena cava filter utilizationAaron C Eifler, Robert J Lewandowski, Ramona Gupta, et al.Journal of Vascular Surgery. Venous and Lymphatic Disorders|January 8, 2019
Single-session inferior vena cava filter removal, recanalization, and endovenous reconstruction for chronic iliocaval thrombosisKush R Desai, Nicholas Xiao, Jennifer Karp, et al.Journal of Vascular and Interventional Radiology : JVIR|February 16, 2026
Safety and feasibility of Y90 radioembolization for cirrhosis-induced splenomegaly and thrombocytopenia: results from an investigational device exemption studyGabriel M Knight, Ahsun Riaz, Christopher Moore, et al.Journal of Vascular and Interventional Radiology : JVIR|March 21, 2015
A Comparison of Retrievability: Celect versus Option FilterRobert K Ryu, Kush Desai, Jennifer Karp, et al.Journal of Vascular and Interventional Radiology : JVIR|November 2, 2010
Improving inferior vena cava filter retrieval rates: impact of a dedicated inferior vena cava filter clinicJeet Minocha, Ibrahim Idakoji, Ahsun Riaz, et al.Journal of Hepatology|April 1, 2014
Prospective randomized pilot study of Y90+/-sorafenib as bridge to transplantation in hepatocellular carcinomaLaura Kulik, Michael Vouche, Sean Koppe, et al.Pageof 2